The Impact of Al2O3 Particles from Grit-Blasted Ti6Al7Nb (Alloy) Implant Surfaces on Biocompatibility, Aseptic Loosening, and Infection

Materials (Basel). 2023 Oct 26;16(21):6867. doi: 10.3390/ma16216867.

Abstract

For the improvement of surface roughness, titanium joint arthroplasty (TJA) components are grit-blasted with Al2O3 (corundum) particles during manufacturing. There is an acute concern, particularly with uncemented implants, about polymeric, metallic, and corundum debris generation and accumulation in TJA, and its association with osteolysis and implant loosening. The surface morphology, chemistry, phase analysis, and surface chemistry of retrieved and new Al2O3 grit-blasted titanium alloy were determined with scanning electron microscopy (SEM), X-ray energy-dispersive spectroscopy (EDS), transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS) and confocal laser fluorescence microscopy, respectively. Peri-prosthetic soft tissue was studied with histopathology. Blasted retrieved and new stems were exposed to human mesenchymal stromal stem cells (BMSCs) for 7 days to test biocompatibility and cytotoxicity. We found metallic particles in the peri-prosthetic soft tissue. Ti6Al7Nb with the residual Al2O3 particles exhibited a low cytotoxic effect while polished titanium and ceramic disks exhibited no cytotoxic effect. None of the tested materials caused cell death or even a zone of inhibition. Our results indicate a possible biological effect of the blasting debris; however, we found no significant toxicity with these materials. Further studies on the optimal size and properties of the blasting particles are indicated for minimizing their adverse biological effects.

Keywords: Al2O3 grit blasting; Ti6Al7Nb implant alloy cementless hip endoprostheses; aseptic loosening; cytotoxicity; infection; osseointegration; roughness; surface and subsurface implant contamination.

Grants and funding

This research was funded by the Slovenian Research Agency, ARRS, (L3-2621, P2-4447 and J3-3066 projects and P2-0132 and P3-0388–Research Programs) awarded to the Institute of Metals and Technology and the University of Ljubljana, Faculty of Health Sciences, tertiary projects of the Department of Orthopaedic Surgery of University Medical Centre Ljubljana, UMCLJ 20210029 and UMCLJ 201900684, and EUREKA IMPLANT BLASTER, C2130-30-090033.